References
- Basch E, Deal AM, Dueck AC, et al. Overall survival results of a randomized trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017; 318(2): 197–198.
- McGettigan S, Rubin KM. PD-1 inhibitor therapy: consensus statement from the faculty of the Melanoma Nursing Initiative on managing adverse events. Clin J Oncol Nurs. 2017; 21(4 Suppl): 42–51.